Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

103.69 +6.80 (+7.02%)
Streaming Delayed Price Updated: 2:05 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 778,440
Open 102.53
Bid (Size) 103.47 (1)
Ask (Size) 103.92 (2)
Prev. Close 96.89
Today's Range 101.06 - 107.39
52wk Range 9.600 - 115.60
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS).
UA fundamental and technical analysis of (NASDAQ:WGS): nlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS). 
Via Chartmill
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million
GeneDx (NASDAQ: WSG) to acquire Fabric Genomics, pioneer in AI-powered genomic interpretation, for up to $51 million. Expanding global reach and improving precision diagnostics. 
Via Benzinga

Performance

YTD
+30.2%
+30.2%
1 Month
+0.5%
+0.5%
3 Month
+39.4%
+39.4%
6 Month
+79.4%
+79.4%
1 Year
+898.0%
+898.0%

More News

Read More
IBD 50's GeneDx Inks $84 Million AI-Tied Takeover Deal
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
From GeneDx
Via Business Wire
Why GENEDX HOLDINGS CORP (NASDAQ:WGS) could fit Mark Minervini’s high-growth criteria
Via Chartmill
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
From GeneDx
Via Business Wire
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
From GeneDx
Via Business Wire
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx
Via Business Wire
Unlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS).
Via Chartmill
Does GENEDX HOLDINGS CORP (NASDAQ:WGS) align with Mark Minervini’s trading strategy?
Via Chartmill
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies
From GeneDx
Via Business Wire
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting
From GeneDx
Via Business Wire
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis
From GeneDx
Via Business Wire
SPY Trying To Find A Floor At The 200 SMA; One New Swing
Via Talk Markets
Topics Stocks / Equities
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
From GeneDx
Via Business Wire
Powerful UnR Session As All Four Market Indices Lockstep Rally Into The Close; Bear Trap Set?
Via Talk Markets
Topics Stocks / Equities
Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols
From GeneDx
Via Business Wire
Top Biotech GeneDx Catapults 42% After Obliterating Earnings Forecasts
Via Investor's Business Daily
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025
From GeneDx
Via Business Wire
Earnings Scheduled For February 18, 2025
Via Benzinga

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 103.69
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 04/23/25 02:05 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.